课题基金 / 基金详情

ADMINISTRATION OF ROSIGLITAZONE IN PATIENTS WITH SLEEP APNEA

ADMINISTRATION OF ROSIGLITAZONE IN PATIENTS WITH SLEEP APNEA
睡眠呼吸暂停患者服用罗格列酮
批准号:
7625761
负责人:
ALEXANDROS N VGONTZAS
金额:
$5.74万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2008-03-31

项目摘要

项目成果

ALEXANDROS N VGONTZAS的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary hypothesis of this study is that insulin resistance/visceral obesity is a pathogenetic factor in obstructive sleep apnea and is a primary determinant of its clinical severity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECTS OF PARTIAL SLEEP DEP &/OR RECOVERY SLEEP ON SLEEPINESS&CYTOKINE SECRETI
IL-6 SECRETION AND QUANTITY AND QUALITY OF SLEEP: AGE AND GENDER EFFECTS
IL-6 SECRETION AND QUANTITY AND QUALITY OF SLEEP: AGE AND GENDER EFFECTS
EFFECTS OF PARTIAL SLEEP DEP &/OR RECOVERY SLEEP ON SLEEPINESS&CYTOKINE SECRETI
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data